GeoVax Labs (NASDAQ:GOVX) had its price target lowered by analysts at D. Boral Capital from $9.00 to $6.00. They now have a "buy" rating on the stock.
Geovax Labs Inc (GOVX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
GeoVax Labs files to sell 11.9M shares of common stock for holders [Seeking Alpha]
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025 [Yahoo! Finance]